亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

文拉法辛 CAS號(hào): 93413-69-5

 
 
單價(jià) 面議對(duì)比
詢(xún)價(jià) 暫無(wú)
發(fā)貨 湖北隨州市付款后3天內(nèi)
型號(hào) 93413-69-5
過(guò)期 長(zhǎng)期有效
更新 2020-06-18 10:08
 

隨州市紅旗化工有限公司

企業(yè)會(huì)員第15年
資料未認(rèn)證
保證金未繳納
  • 湖北-隨州市
  • 上次登錄 2023-06-07
  • 閆先生 (先生)   經(jīng)理
詳細(xì)說(shuō)明
文拉法辛
CAS號(hào): 93413-69-5
中文同義詞: 2-(4-甲氧基苯基)-2-(1-環(huán)己醇基)乙胺出現(xiàn)被限制詞語(yǔ);頑發(fā)克星;維拉法司;禁發(fā) 鹽酸文法拉新;萬(wàn)拉法新;(R/S)-1-[2-(二甲胺)-1-(4-甲氧苯基)乙基]環(huán)己醇;文拉法辛;(±)-1-[2-(二甲氨基)-1-(4-甲氧苯基)乙基]環(huán)己醇
英文名稱(chēng): Venlafaxine
分子式: C17H27NO2
分子量: 277.4
性狀:白色或類(lèi)白色結(jié)晶
標(biāo)準(zhǔn):企業(yè)標(biāo)準(zhǔn)
含量:≥98.5~101.0%
用途:用途  能同時(shí)抑制5-羥色胺和去甲腎上腺素的回收。用于抗抑郁。
包裝:25kg/桶
舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
來(lái)氟米特 CAS號(hào): 75706-12-6 頭孢曲松鈉 CAS;74578-69-1 福多斯坦 CAS號(hào): 13189-98-5 克洛索隆 CAS;60200-06-8 磷酸吡哆醛 CAS號(hào): 54-47-7 4-甲基噻唑-5-甲醛 CAS號(hào): 82294-70-0 三氯苯噠唑 CAS:68786-66-3 5-乙酰水楊酸甲酯 CAS;16475-90-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |